Top compounds associated with response to SPATA21


Feature Type Standardized
Nominal ANOVA
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.058 0.07
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.061 0.07
mRNA CIL56 CTRPv2 pan-cancer AAC 0.081 0.07
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.059 0.07
mRNA JQ-1:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.06 0.07
mRNA BRD-K51490254 CTRPv2 pan-cancer AAC 0.066 0.07
mRNA clofarabine CTRPv2 pan-cancer AAC 0.051 0.07
mRNA MI-2 CTRPv2 pan-cancer AAC 0.092 0.08
mRNA BAY 61-3606 GDSC1000 pan-cancer AAC 0.06 0.08
mRNA PD 153035 CTRPv2 pan-cancer AAC -0.072 0.08
Download CSV